CTDSPL2 and cancer: In acute myeloid leukemia (AML), CTDSPL2 dephosphorylates the kinases STK35 and PDIK1L, supporting the proliferation of AML cancer cells and affecting the expression of genes involved in amino acid biosynthesis and transport [15].